Our presumed diagnosis was bilateral sacroililitis secondary to psoriatic arthritis, and the patient was started on adalimumab, a tumor necrosis factor alpha blocker (TNF alpha) therapy. The gene discussed is TNF; the disease is psoriatic arthritis.